Print this page
-
Cutaneous Oncology Clinical Database and Biospecimen Bank
Protocol: 002233Principal Investigator:
- Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
Video Education with Result Dependent dIsclosure (VERDI)
Protocol: 042207Principal Investigator:
- Deborah L Toppmeyer
Applicable Disease Sites: Breast
Colon
Kidney
Melanoma, Skin
Ovary
Pancreas
Prostate
Soft Tissue -
Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination with Pembrolizumab Versus Investigator's Choice in HLAA*02:01-Positive Participants with Previously Treated Advanced Melanoma.
Protocol: 092203Principal Investigator:
- Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
A Phase I Study to Evaluate the Safety of Naltrexone and Propranolol in Combination with Standard of Care Ipilimumab and Nivolumab in Patients with Advanced Melanoma.
Protocol: 092302Principal Investigator:
- Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
A Phase 2 and Phase 3 Peri-Operative trial of Fianlimab and Cemiplimab Compared with Pembrolizumab in Patients with Resectable Stage III and IV Melanoma.
Protocol: 092303Principal Investigator:
- Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
A Phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO).
Protocol: 092305Principal Investigator:
- Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab versus Relatlimab and Nivolumab in Participants with Unresectable or Metastatic Melanoma.
Protocol: 092402Principal Investigator:
- Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
Facebook Intervention for Young Onset Melanoma Patients and Families.
Protocol: 131812Principal Investigator:
- Sharon Manne
Applicable Disease Sites: Melanoma, Skin -
Understanding Sun Protection and Skin Examination Practices Among Hispanics.
Protocol: 132111Principal Investigator:
- Carolyn J Heckman
Applicable Disease Sites: Melanoma, Skin -
A Digital Intervention to Improve Skin Self-Examination Among Melanoma Survivors.
Protocol: 132202Principal Investigator:
- Sharon Manne
Applicable Disease Sites: Melanoma, Skin -
Developing and Testing a Mobile Health Intervention to Promote Sun Protection Behaviors and Skin Examination Among Hispanics.
Protocol: 132206Principal Investigator:
- Zhaomeng Niu
Applicable Disease Sites: Other Skin